(2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid

C31H46Br2O5 — CID 11273812

IUPAC(2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid
SMILESCC(=O)O[C@H]1C[C@@]2(C)C(C[C@@H](O)[C@H]3[C@@]4(C)CC[C@H](Br)[C@@H](C)C4CC[C@@]32C)/C1=C(\CCC(Br)=C(C)C)C(=O)O
InChIInChI=1S/C31H46Br2O5/c1-16(2)22(32)9-8-19(28(36)37)26-21-14-24(35)27-29(5)12-11-23(33)17(3)20(29)10-13-30(27,6)31(21,7)15-25(26)38-18(4)34/h17,20-21,23-25,27,35H,8-15H2,1-7H3,(H,36,37)/b26-19-/t17-,20?,21?,23-,24+,25-,27-,29-,30-,31-/m0/s1
InChIKeyMVPQCRXNHNLSHZ-VMTWGISGSA-N
MW658.51 g/mol
LogP7.79
Rot. Bonds5

About (2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid

(2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid (PubChem CID 11273812) has the molecular formula C31H46Br2O5 and a molecular weight of 658.51 g/mol. Its IUPAC name is (2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid.

Molecular Properties

Compound Name(2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid
PubChem CID11273812
Molecular FormulaC31H46Br2O5
Molecular Weight658.51 g/mol
Exact Mass656.17
IUPAC Name(2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid
SMILESCC(=O)O[C@H]1C[C@@]2(C)C(C[C@@H](O)[C@H]3[C@@]4(C)CC[C@H](Br)[C@@H](C)C4CC[C@@]32C)/C1=C(\CCC(Br)=C(C)C)C(=O)O
InChIInChI=1S/C31H46Br2O5/c1-16(2)22(32)9-8-19(28(36)37)26-21-14-24(35)27-29(5)12-11-23(33)17(3)20(29)10-13-30(27,6)31(21,7)15-25(26)38-18(4)34/h17,20-21,23-25,27,35H,8-15H2,1-7H3,(H,36,37)/b26-19-/t17-,20?,21?,23-,24+,25-,27-,29-,30-,31-/m0/s1
InChIKeyMVPQCRXNHNLSHZ-VMTWGISGSA-N
XLogP7.79
TPSA83.83 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500658.51
LogP ≤ 57.79
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid?
The IUPAC name of (2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid (CID 11273812) is (2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid.
What is the SMILES notation for (2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid?
The canonical SMILES for (2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid is CC(=O)O[C@H]1C[C@@]2(C)C(C[C@@H](O)[C@H]3[C@@]4(C)CC[C@H](Br)[C@@H](C)C4CC[C@@]32C)/C1=C(\CCC(Br)=C(C)C)C(=O)O.
What is the InChIKey of (2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid?
The InChIKey is MVPQCRXNHNLSHZ-VMTWGISGSA-N. The full InChI is InChI=1S/C31H46Br2O5/c1-16(2)22(32)9-8-19(28(36)37)26-21-14-24(35)27-29(5)12-11-23(33)17(3)20(29)10-13-30(27,6)31(21,7)15-25(26)38-18(4)34/h17,20-21,23-25,27,35H,8-15H2,1-7H3,(H,36,37)/b26-19-/t17-,20?,21?,23-,24+,25-,27-,29-,30-,31-/m0/s1.
What are the key properties of (2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid?
(2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid has a molecular weight of 658.51 g/mol, XLogP of 7.79, 5 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (2Z)-2-[(3S,4S,8S,9S,10S,11R,14S,16S)-16-acetyloxy-3-bromo-11-hydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-5-bromo-6-methylhept-5-enoic acid is sourced from PubChem (CID 11273812), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).